1001667-23-7 | 2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-

Availability
Typically In Stock

Description

• Catalog Number: AA01258
• Chemical Name: 2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-
• CAS Number: 1001667-23-7
• Molecular Formula: C43H53N5O8S
• Molecular Weight: 799.9746
• MDL Number: MFCD22543894
• SMILES: COc1ccc2c(c1)nc(cc2O[C@@H]1C[C@H](N(C1)C(=O)[C@H](C(C)(C)C)CC(=O)N1CCCCC1)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1)c1ccccc1

Upstream Synthesis Route

Sovaprevir, a potent protease inhibitor, is widely used in chemical synthesis as a key reagent for the construction of complex molecular structures. Specifically, Sovaprevir plays a crucial role in facilitating the formation of peptide bonds during peptide synthesis. Its high specificity towards the target enzyme makes it an essential tool for manipulating and modifying peptide sequences with precision and efficiency. With its ability to selectively inhibit protease activity, Sovaprevir enables chemists to control the synthesis of peptides and proteins with great accuracy, leading to the creation of novel bioactive molecules and pharmaceutical compounds. In addition, Sovaprevir's compatibility with a variety of reaction conditions and its stability make it a versatile choice for synthetic chemists seeking to streamline their processes and achieve high yields of desired products. By incorporating Sovaprevir into chemical syntheses, researchers can accelerate the development of new drugs, explore new avenues in protein engineering, and advance the field of organic chemistry.